Segal Trials

This Thanksgiving, we want to express our gratitude to all who have supported our clinical trials – from participants to healthcare professionals. Your contributions make a difference in mental health research!

Celebrating Our Amazing Team at Segal Trials! 🎉🍪   At Segal Trials, we know our success is driven by the incredible dedication, passion, and expertise of our team. 💙 Recently, we took a moment to show our appreciation with a sweet treat—a small token to say THANK YOU for all that you do!   📸 These pictures capture the joy, teamwork, and positive energy that define Segal Trials. Seeing our team come together (and enjoy some cookies!) is a reminder of why we’re so proud to be part of this incredible organization.   We’re also thrilled to share the amazing feedback we received at the recent CNS Summit about the outstanding work happening here. This recognition belongs to each of you, as it reflects the passion and commitment you bring every day. 🌟   #TeamSegal #Gratitude #ClinicalResearch #CNSummit #ThankYou

We had an incredible experience attending the 15th Anniversary CNS Summit! Connecting with industry leaders, exploring innovative clinical research strategies, and celebrating 15 years of advancements in the neuroscience field—this event was truly inspiring. We're excited to take the knowledge and connections we gained here back to our work, advancing mental health research for a brighter future. Segal Trials has been proud to be part of CNS Summit since its inception. Witnessing the growth and impact of such a valuable meeting in the life sciences industry has been incredibly rewarding. Here is to many more years of innovation, collaboration, and success together! Swipe through to see some of our favorite moments! #SegalTrials #CNSSummit #ClinicalResearch #Neuroscience #MentalHealth #Innovation #ResearchCommunity

We're proud to share that our Chief Scientific Officer and Medical Director, Dr. Rishi Kakar, was recently quoted in MedPage Today discussing the latest long-term findings on Cobenfy. Highlighting the importance of long-term efficacy and tolerability for patients. Dr. Kakar emphasized the significance of consistent data over 52 weeks, especially given the chronic nature of illnesses like schizophrenia. This data supports both providers and patients with confidence in sustained symptom improvement. Read the full article here for more insights: https://hubs.ly/Q02XJftn0 #SegalTrials #ClinicalResearch #MentalHealth #Schizophrenia #Cobenfy

Honoring our veterans today for their courage and sacrifice. Thank you for your service. 🇺🇸 At Segal Trials, we recognize the unique mental health challenges veterans face and are committed to advancing research that provides support and healing. #VeteransDay #MentalHealth

🎃 Celebrating Team Spirit this Halloween! 👻 As we step into November, we’re looking back on the fantastic Halloween celebration we had together! Our team brought incredible energy, creativity, and a lot of laughs with their costumes and festive spirit. We’re grateful for the moments that bring us closer and strengthen our bond as a team. Here’s to many more celebrations together! 🧡 #Halloween2024 #TeamCulture #LifeAtSegalTrials #TogetherWeThrive

The Segal Trials team is thrilled to be attending the CNS Summit 2024 from November 10th to 13th in Boston, MA. We’re looking forward to connecting with other industry leaders and exploring innovations in clinical trials, research advancements, and patient-centered solutions for CNS and beyond. Schedule a meeting with us at CNS Summit to learn more about our early and late phase capabilities. Secure your spot today by emailing newbusiness@segaltrials.com #CNSSummit2024 #SegalTrials #ClinicalResearch #Innovation #MentalHealth

The Segal Trials team is thrilled to be attending the CNS Summit 2024 from November 10th to 13th in Boston, MA. We’re looking forward to connecting with other industry leaders and exploring innovations in clinical trials, research advancements, and patient-centered solutions for CNS and beyond. Schedule a meeting with us at CNS Summit to learn more about our early and late phase capabilities. Secure your spot today by emailing newbusiness@segaltrials.com #CNSSummit2024 #SegalTrials #ClinicalResearch #Innovation #MentalHealth

👏 Dr. Rishi Kakar!

Dr. Rishi Kakar, investigator in the EMERGENT program, shares his thoughts on the recent FDA approval of a new class of medicine for the treatment of #schizophrenia in adults. We wish to extend our deepest appreciation to the patients, researchers and healthcare professionals who participated in the trials, without whom this landmark approval would not have been possible. Learn more: https://bit.ly/3YeakbT